| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C281-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-15 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C281-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-71 |
| filingDate |
1999-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18c767c30bf8002cd74db236833f8e84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4155998854ac8b304944e478ecbde5ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5f96b225f5e5d0a45cbd306b3e1f002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d14da4af250fe5a1cc2d9fa42e6c0504
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b3e7b53784c03f6edcd11cf540b4da5 |
| publicationDate |
1999-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9952936-A2 |
| titleOfInvention |
Arginine peptide analogs useful as fibroblast growth factor antagonists |
| abstract |
Pharmaceutical compositions containing arginine amides, peptides or analogs and methods for using the pharmaceutical compositions for modulating the activity of the FGF family of peptides are provided. Methods for inhibiting the binding of an FGF peptide to an FGF receptor by contacting the receptor with arginine amides, peptides or analogs of formulae (I) or (II) are provided. Methods for treating FGF-mediated disorders by administering effective amounts of one or more of these compounds or pharmaceutically acceptable derivatives thereof that inhibit the activity of one or more FGF peptides are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-6994939-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8148429-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973920-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9227927-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017521494-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9731016-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111233973-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9339461-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309609-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7939505-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8501824-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8410174-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877729-B2 |
| priorityDate |
1998-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |